Paper38136253
The Heart of the Matter: Immune Checkpoint Inhibitors and Immune-Related Adverse Events on the Cardiovascular System.
Green CE and 8 others. Cancers (Basel), 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. The Heart of the Matter: Immune Checkpoint Inhibitors and Immune-Related Adverse Events on the Cardiovascular System. Papers, record 38136253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Heart of the Matter: Immune Checkpoint Inhibitors and Immune-Related Adverse Events on the Cardiovascular System.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30124874 | PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity. | J Clin Endocrinol Metab | 2018 | https://conductscience.org/library/papers/30124874 | PubMed |
| 2 | 34552304 | Metabolic disease and adverse events from immune checkpoint inhibitors. | Eur J Endocrinol | 2021 | https://conductscience.org/library/papers/34552304 | PubMed |
| 3 | 33436486 | Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33436486 | PubMed |
| 4 | 33705549 | Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy. | J Natl Cancer Inst | 2021 | https://conductscience.org/library/papers/33705549 | PubMed |
| 5 | 11209085 | Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. | Science | 2001 | https://conductscience.org/library/papers/11209085 | PubMed |
| 6 | 36040835 | Cardiovascular complications of immune checkpoint inhibitors for cancer. | Eur Heart J | 2022 | https://conductscience.org/library/papers/36040835 | PubMed |
| 7 | 32425791 | Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32425791 | PubMed |
| 8 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 9 | 23395974 | Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. | Circulation | 2013 | https://conductscience.org/library/papers/23395974 | PubMed |
| 10 | 28763371 | Proinflammatory Cytokines Mediate GPCR Dysfunction. | J Cardiovasc Pharmacol | 2017 | https://conductscience.org/library/papers/28763371 | PubMed |
| 11 | 28817755 | Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/28817755 | PubMed |
| 12 | 17938288 | Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. | Circulation | 2007 | https://conductscience.org/library/papers/17938288 | PubMed |
| 13 | 28066423 | T Cell Trafficking through Lymphatic Vessels. | Front Immunol | 2016 | https://conductscience.org/library/papers/28066423 | PubMed |
| 14 | 31901074 | Targeted deletion of PD-1 in myeloid cells induces antitumor immunity. | Sci Immunol | 2020 | https://conductscience.org/library/papers/31901074 | PubMed |
| 15 | 33826117 | A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors. | J Med Toxicol | 2021 | https://conductscience.org/library/papers/33826117 | PubMed |
| 16 | 7584144 | Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. | Immunity | 1995 | https://conductscience.org/library/papers/7584144 | PubMed |
| 17 | 34868071 | Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34868071 | PubMed |
| 18 | 34723640 | Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. | Circulation | 2021 | https://conductscience.org/library/papers/34723640 | PubMed |
| 19 | 25705383 | Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome. | J Immunother Cancer | 2015 | https://conductscience.org/library/papers/25705383 | PubMed |
| 20 | 1785943 | The level of urinary epidermal growth factor is not influenced by the extent of psoriatic lesions. | Arch Dermatol Res | 1991 | https://conductscience.org/library/papers/1785943 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42838936 | Blocking PD1 prevents T-cell-promoted fibrosis in myocardial infarction. | Cell Discov | 2026 | https://conductscience.org/library/papers/42838936 | PubMed |
| 42724286 | A narrative review of immune checkpoint inhibitor-related cardiotoxicity in lung cancer: mechanisms, risk stratification, and clinical management. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42724286 | PubMed |
| 42394485 | [Analysis of cardiovascular adverse events associated with 8 immune checkpoint inhibitors based on the FAERS database]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42394485 | PubMed |
| 42196366 | Immune-Checkpoint-Inhibitor-Related Cardiovascular Toxicities in Cancer: A Mechanistic Review of Molecular Pathways with AI-Assisted Literature Clustering. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196366 | PubMed |
| 40693234 | The role of exosomes in bladder cancer immunotherapy. | J Natl Cancer Cent | 2025 | https://conductscience.org/library/papers/40693234 | PubMed |
| 40673965 | Immune checkpoint inhibitors and cardiovascular toxicity: immunology, pathophysiology, diagnosis, and management. | J Thromb Thrombolysis | 2025 | https://conductscience.org/library/papers/40673965 | PubMed |
| 40149521 | Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy? | Biomedicines | 2025 | https://conductscience.org/library/papers/40149521 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136253
GET https://conductscience.org/api/papers/v1/38136253/references?page=2